Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07126795Phase 1Not yet recruiting
Phase 1, randomised trial in burn injury comparing Magnesium Sulfate Arm with Normal Saline Placebo Arm (2 arms). Primary endpoints: Severe Adverse Events at 1 year, Protocol Deviations at 1 year and 5 more. Planned start Dec 2027; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07126795.